Squarepoint Ops LLC Seagen Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $311,107 - $341,962	-1,658 Reduced 4.25%	37,365 $7.19 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $8.9 Million - $14.2 Million	-69,758 Reduced 64.13%	39,023 $7.9 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $15.5 Million - $18.4 Million	-132,123 Reduced 54.84%	108,781 $14 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $31.7 Million - $42.1 Million	234,004 Added 3391.36%	240,904 $33 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $1.83 Million - $3.01 Million	-16,791 Reduced 70.88%	6,900 $1.22 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.44 Million - $1.9 Million	12,030 Added 103.16%	23,691 $3.41 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $16.3 Million - $19.5 Million	-120,976 Reduced 91.21%	11,661 $1.84 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $11.2 Million - $15.6 Million	81,708 Added 160.44%	132,637 $18.4 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $8.38 Million - $10.8 Million	50,929 New	50,929 $8.92 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.